By Igor Kossov ( June 24, 2014, 3:47 PM EDT) -- A Pennsylvania federal court ruled Monday that only one of three whistleblowers can take a portion of Endo Pharmaceuticals Inc.'s $193 million settlement with the U.S. Department of Justice over the off-label marketing of the pain-relief patch Lidoderm, saying only the first to file suit is entitled to the award....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.